Literature DB >> 24378065

Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease.

Nagaendran Kandiah1, Russell Chander2, Angeline Zhang2, Cheong Chin Yee2.   

Abstract

OBJECTIVES: To study the association between cerebral white matter disease and burden of behavioral and psychological symptoms (BPSD) among patients with moderate to severe AD.
METHODS: Patients with moderate to severe AD having undergone MRI brain, cognitive and behavioral evaluations were studied. BPSD was diagnosed based on established clinical guidelines. White matter hyperintensity (WMH) and medial temporal lobe atrophy (MTA) were quantified by a blinded rater.
RESULTS: 122 AD patients were studied. Age [76.84 vs. 72.70, p = 0.014] and MMSE [11.69 vs. 15.16, p < 0.001] was significantly higher in patients with BPSD. BPSD patients demonstrated higher periventricular [5.44 vs. 4.21, p < 0.001], deep subcortical [5.07 vs. 3.43, p < 0.001], and total WMH [10.51 vs. 7.65, p < 0.001] compared to non-BPSD patients. Higher proportion of BPSD patients had WMH in the highest tertile of severity (82.22% vs. 45.45%, p < 0.001). After correcting for age, baseline cognition and degree of MTA, total WMH remained significantly associated with a diagnosis of BPSD [odds ratio: 1.45 (1.14-1.85; p = 0.002)]. With severe WMH, the association is significantly increased [odds ratio: 4.3 (1.3-12.5); p = 0.016].
CONCLUSION: WMH is independently associated with BPSD in moderate to severe AD. Optimizing vascular risk factors may be a strategy to reduce the severity of BPSD in AD.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Behavioral and psychological symptoms of dementia (BPSD); Cerebral ischemia; Magnetic resonance imaging; Neuropsychology; White matter disease

Mesh:

Year:  2013        PMID: 24378065     DOI: 10.1016/j.jns.2013.11.042

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.

Authors:  Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella
Journal:  Nurs Outlook       Date:  2017-06-16       Impact factor: 3.250

Review 2.  Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Authors:  Kentaro Hirao; Gregory M Pontone; Gwenn S Smith
Journal:  Neurosci Biobehav Rev       Date:  2014-11-20       Impact factor: 8.989

3.  The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease.

Authors:  Zhiyu Cao; Yingren Mai; Wenli Fang; Ming Lei; Yishan Luo; Lei Zhao; Wang Liao; Qun Yu; Jiaxin Xu; Yuting Ruan; Songhua Xiao; Vincent C T Mok; Lin Shi; Jun Liu
Journal:  Front Hum Neurosci       Date:  2022-06-14       Impact factor: 3.473

4.  Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease.

Authors:  Shusuke Yagi; Tomoya Hara; Rie Ueno; Ken-ichi Aihara; Daiju Fukuda; Akira Takashima; Junko Hotchi; Takayuki Ise; Koji Yamaguchi; Takeshi Tobiume; Takashi Iwase; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Masashi Akaike; Masataka Sata
Journal:  Nutr J       Date:  2014-12-04       Impact factor: 3.271

5.  Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Jung-Lung Hsu; Wei-Ju Lee; Yi-Chu Liao; Jiing-Feng Lirng; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

6.  Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer's disease.

Authors:  Jung-Lung Hsu; Wei-Ju Lee; Yi-Chu Liao; Jiing-Feng Lirng; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

7.  Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment.

Authors:  Noriko Ogama; Takashi Sakurai; Naoki Saji; Toshiharu Nakai; Shumpei Niida; Kenji Toba; Hiroyuki Umegaki; Masafumi Kuzuya
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-04-11

8.  Profile of the Paraoxonase 1 (PON1) Gene 192Q/R Polymorphism and Clinical Associations among Older Singaporean Chinese with Alzheimer's and Mixed Dementia.

Authors:  Dennis C C Seow; Qi Gao; Philip Yap; Jia Min Gan; Hui Ling Chionh; Su Chi Lim; Lei Feng; Tze Pin Ng
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-02-17

Review 9.  Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®.

Authors:  Nagaendran Kandiah; Paulus Anam Ong; Turana Yuda; Li-Ling Ng; Kaysar Mamun; Reshma Aziz Merchant; Christopher Chen; Jacqueline Dominguez; Simeon Marasigan; Encarnita Ampil; Van Thong Nguyen; Suraya Yusoff; Yee Fai Chan; Fee Mann Yong; Orapitchaya Krairit; Chuthamanee Suthisisang; Vorapun Senanarong; Yong Ji; Ramesh Thukral; Ralf Ihl
Journal:  CNS Neurosci Ther       Date:  2019-02       Impact factor: 5.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.